Clinical Trial Update: A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries [NA]

View source ↗

Summary

Clinical trial registry entry for Sperstent device used on residual lesions in femoropopliteal arteries; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Dissection
• Arterial Stenosis
• Peripheral Arterial Disease

Drugs mentioned

• Sperstent

Snippet

Sponsor: FrontAce Scientific Co., Ltd | Conditions: Peripheral Arterial Disease, Stenosis | NA | Status: RECRUITING